During the last several decades, the use of Cerebrolysin for therapy of cerebral disorders has been studied in newborns, premature infants, and children with brain damage. These studies have shown that Cerebrolysin can improve cognitive functions, increase brain bioelectrical activity, and enhance reflexes. Cerebrolysin can also improve the symptoms of strokes, Alzheimer’s disease, and traumatic brain injuries.
Cerebrolysin is an amino acid-based peptide which can be administered directly to nerve cells. Its low molecular weight (MW) allows it to pass through the blood-brain barrier. Its antioxidant potential makes it effective in protecting the brain from oxidative stress. Cerebrolysin can also stimulate the growth of new neurons.
The production of Cerebrolysin involves a high-tech, gentle process. It contains more than 100 oligopeptides that are essential for the neurochemistry of the brain.
It contains a stable collagen motif, which may help the body to synthesize new supporting proteins. Cerebrolysin peptide also contains nerve growth factor (NGF), which promotes the growth and differentiation of neurons.
Cerebrolysin is considered as an essential source of amino acids. These amino acids have an effect on several nervous processes such as arousal, inhibition, sleep, wakefulness, and neuroplasticity.
Cerebrolysin is a potent antioxidant oligopeptide, which participates in redox reactions. It can also protect neurons from harmful effects of free radicals. Cerebrolysin also has the ability to protect nerve cells from toxic protein aggregates. It can also be used to improve cardiac circulation.
Cerebrolysin is one of the best-known neurotrophic agents. It has been used in Europe to treat neurological disorders such as strokes, dementia, and traumatic brain injuries.